Loading
IARC estimates 849 new cancer cases and 472 cancer deaths in Brunei in 2024; the commonest new cancers are colorectum, breast and trachea, bronchus and lung. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Colorectum | 145 | 28.4 | Colorectal cancer |
| Breast | 128 | 48.3 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Trachea, bronchus and lung | 98 | 20.1 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Non-Hodgkin lymphoma | 46 | 9.0 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Prostate | 43 | 19.7 | Prostate cancer |
| Cervix uteri | 42 | 15.7 | Cervical cancer |
| Liver and intrahepatic bile ducts | 37 | 7.5 | Hepatocellular carcinoma |
| Corpus uteri | 35 | 13.2 | Endometrial cancer |
| Nasopharynx | 29 | 5.7 | |
| Stomach | 29 | 6.0 | Gastric & gastro-oesophageal junction cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Trachea, bronchus and lung | 85 | 17.6 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Colorectum | 71 | 14.2 | Colorectal cancer |
| Breast | 53 | 20.0 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Liver and intrahepatic bile ducts | 37 | 7.5 | Hepatocellular carcinoma |
| Stomach | 24 | 5.1 | Gastric & gastro-oesophageal junction cancer |
| Leukaemia | 24 | 5.5 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Non-Hodgkin lymphoma | 20 | 4.0 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Cervix uteri | 18 | 6.7 | Cervical cancer |
| Nasopharynx | 16 | 3.2 | |
| Pancreas | 15 | 3.0 | Pancreatic ductal adenocarcinoma |
No trial record in OnCo lists a site in Brunei. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Brunei.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Brunei is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Brunei is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.